首页> 外文期刊>Population health metrics >Cancer survival for Aboriginal and Torres Strait Islander Australians: a national study of survival rates and excess mortality
【24h】

Cancer survival for Aboriginal and Torres Strait Islander Australians: a national study of survival rates and excess mortality

机译:澳大利亚原住民和托雷斯海峡岛民的癌症生存率:生存率和超额死亡率的全国研究

获取原文
           

摘要

Background National cancer survival statistics are available for the total Australian population but not Indigenous Australians, although their cancer mortality rates are known to be higher than those of other Australians. We aimed to validate analysis methods and report cancer survival rates for Indigenous Australians as the basis for regular national reporting. Methods We used national cancer registrations data to calculate all-cancer and site-specific relative survival for Indigenous Australians (compared with non-Indigenous Australians) diagnosed in 2001-2005. Because of limited availability of Indigenous life tables, we validated and used cause-specific survival (rather than relative survival) for proportional hazards regression to analyze time trends and regional variation in all-cancer survival between 1991 and 2005. Results Survival was lower for Indigenous than non-Indigenous Australians for all cancers combined and for many cancer sites. The excess mortality of Indigenous people with cancer was restricted to the first three years after diagnosis, and greatest in the first year. Survival was lower for rural and remote than urban residents; this disparity was much greater for Indigenous people. Survival improved between 1991 and 2005 for non-Indigenous people (mortality decreased by 28%), but to a much lesser extent for Indigenous people (11%) and only for those in remote areas; cancer survival did not improve for urban Indigenous residents. Conclusions Cancer survival is lower for Indigenous than other Australians, for all cancers combined and many individual cancer sites, although more accurate recording of Indigenous status by cancer registers is required before the extent of this disadvantage can be known with certainty. Cancer care for Indigenous Australians needs to be considerably improved; cancer diagnosis, treatment, and support services need to be redesigned specifically to be accessible and acceptable to Indigenous people.
机译:背景信息尽管已知澳大利亚癌症总死亡率高于其他澳大利亚人,但可提供澳大利亚总人口的国家癌症生存统计数据,但澳大利亚原住民则无法获得。我们旨在验证分析方法并报告澳大利亚原住民的癌症生存率,以此作为定期国家报告的基础。方法我们使用国家癌症登记数据计算2001年至2005年诊断出的澳大利亚原住民(与非澳大利亚原住民相比)的全癌和特定部位相对生存率。由于土著生命表的可用性有限,我们验证了特定原因的生存率(而非相对生存率),并进行了比例风险回归分析,以分析1991年至2005年所有癌症生存率的时间趋势和区域差异。结果土著生存率较低比非土著澳大利亚人在所有癌症和许多癌症部位的综合患病率更高。癌症原住民的超额死亡率仅限于诊断后的前三年,而在第一年最高。农村和边远地区的生存率低于城市居民;对于土著人来说,这种差距更大。 1991年至2005年间,非土著人民的生存率提高了(死亡率降低了28%),但土著人民的生存率却下降了很多(11%),并且仅针对偏远地区的人们;城市土著居民的癌症生存率并未提高。结论对于所有合并的癌症和许多单个癌症位点,土著居民的癌症存活率均低于其他澳大利亚人,尽管在确定这种不利程度之前还需要通过癌症登记簿更准确地记录土著居民的状况。澳大利亚土著人的癌症护理需要大大改善;癌症的诊断,治疗和支持服务需要专门重新设计,以使土著人民能够获得和接受。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号